secwatch.observer — SEC 8-K summary
======================================

Issuer:     Repare Therapeutics Inc. (—)
CIK:        0001808158
Form:       8-K/A
Filed at:   2025-06-02T23:59:59+00:00
Accession:  0001193125-25-133312
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Repare Therapeutics discloses employment terms for CAO Sandra Alves: CA$350k salary, 35% bonus target
--------------------------------------------------------------------------------

- Annual base salary: CA$350,000; target annual cash bonus: 35% of base salary.
- Non-change-in-control severance: 7 months' salary, benefits continuation, 6-month vesting acceleration.
- Change-in-control severance: lump sum of base salary plus higher of target or prior year bonus, 12 months benefits, full vesting.
- Employment agreement entered May 28, 2025, effective with Ms. Alves' appointment as CAO.
- Agreement will be filed with Q2 2025 Form 10-Q.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1808158/000119312525133312/0001193125-25-133312-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1808158/000119312525133312/d925343d8ka.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-133312

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer